Treatable traits in systemic sclerosis

F Amati, G Bongiovanni, A Tonutti, F Motta… - Clinical Reviews in …, 2023 - Springer
Systemic sclerosis (SSc) is a chronic systemic disease within the spectrum of connective
tissue diseases, specifically characterized by vascular abnormalities and inflammatory and …

Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development

FV Castelino, J Varga - Expert Review of Clinical Immunology, 2013 - Taylor & Francis
Systemic sclerosis (SSc) is a clinically heterogeneous orphan disease of unknown etiology
and no effective therapy. It is characterized by protean manifestations, an unpredictable …

A narrative review of pathogenetic and histopathologic aspects, epidemiology, classification systems, and disease outcome measures in systemic sclerosis

MG Lazzaroni, S Piantoni, F Angeli, S Bertocchi… - Clinical reviews in …, 2023 - Springer
Systemic sclerosis (SSc) is a rare systemic autoimmune disease, characterized by the
presence of three main actors: vasculopathy, immune activation, and fibrosis. This …

Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment

AJ Affandi, TRDJ Radstake, W Marut - Seminars in immunopathology, 2015 - Springer
Systemic sclerosis (SSc) is a complex autoimmune disease in which immune activation,
vasculopathy, and extensive fibrosis of the skin and internal organs are among the principal …

[HTML][HTML] Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels

RL Smeets, BE Kersten, I Joosten, C Kaffa… - Autoimmunity …, 2020 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disease which is characterized by vasculopathy,
tissue fibrosis and activation of the innate and adaptive immune system. Clinical features of …

Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets

M Mahler, M Hudson, C Bentow, F Roup, L Beretta… - Autoimmunity …, 2020 - Elsevier
Systemic sclerosis (SSc) is a rare chronic disease of unknown etiology characterized by
vascular abnormalities and fibrosis involving the skin and internal organs, especially the …

Personalized medicine in systemic sclerosis: facts and promises

R Dobrota, C Mihai, O Distler - Current rheumatology reports, 2014 - Springer
The concept of personalized medicine has led to a paradigm shift in recent years. It
integrates multiple clinical and biological levels of investigation aimed at offering the best …

Toward molecular stratification and precision medicine in systemic sclerosis

M Noviani, VR Chellamuthu, S Albani… - Frontiers in Medicine, 2022 - frontiersin.org
Systemic sclerosis (SSc), a complex multi-systemic disease characterized by immune
dysregulation, vasculopathy and fibrosis, is associated with high mortality. Its pathogenesis …

Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians

S Keret, D Rimar, P Lansiaux, E Feldman… - Autoimmunity …, 2023 - Elsevier
Systemic sclerosis (SSc) is a rare and chronic autoimmune disease characterized by a
pathogenic triad of immune dysregulation, vasculopathy, and progressive fibrosis. Clinical …

Controversies: molecular vs. clinical systemic sclerosis classification

SR Johnson, M Hinchcliff… - Journal of Scleroderma …, 2016 - journals.sagepub.com
Systemic sclerosis (SSc) is a multisystem chronic disease characterized by the three
cardinal pathological features, including autoimmunity/inflammation, vasculopathy, and …